IL142720A - Water-miscible pharmaceutical compositions of paclitaxel - Google Patents

Water-miscible pharmaceutical compositions of paclitaxel

Info

Publication number: IL142720A
Authority: IL; Israel
Prior art keywords: paclitaxel; water; pharmaceutical compositions; miscible pharmaceutical; miscible
Prior art date: 1998-10-30

Application number

IL14272099A

Other languages

English (en)

Other versions

IL142720A0 (en

Original Assignee

Supergen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-30

Filing date

1999-09-22

Publication date

2005-03-20

1999-09-22 Application filed by Supergen Inc filed Critical Supergen Inc

2002-03-10 Publication of IL142720A0 publication Critical patent/IL142720A0/xx

2005-03-20 Publication of IL142720A publication Critical patent/IL142720A/xx

Links

229930012538 Paclitaxel Natural products 0.000 title abstract 2
229960001592 paclitaxel Drugs 0.000 title abstract 2
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
239000003125 aqueous solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IL14272099A 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel IL142720A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/183,199 US6017948A (en)	1998-10-30	1998-10-30	Water-miscible pharmaceutical compositions
PCT/US1999/021990 WO2000025775A1 (en)	1998-10-30	1999-09-22	Water-miscible pharmaceutical compositions of paclitaxel

Publications (2)

Publication Number	Publication Date
IL142720A0 IL142720A0 (en)	2002-03-10
IL142720A true IL142720A (en)	2005-03-20

Family

ID=22671864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14272099A IL142720A (en)	1998-10-30	1999-09-22	Water-miscible pharmaceutical compositions of paclitaxel

Country Status (11)

Country	Link
US (1)	US6017948A (de)
EP (1)	EP1124549B1 (de)
JP (1)	JP2002528494A (de)
CN (1)	CN1178655C (de)
AT (1)	ATE254455T1 (de)
AU (1)	AU775158B2 (de)
CA (1)	CA2345697A1 (de)
DE (1)	DE69912983D1 (de)
IL (1)	IL142720A (de)
MX (1)	MXPA01004268A (de)
WO (1)	WO2000025775A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6774278B1 (en) *	1995-06-07	2004-08-10	Cook Incorporated	Coated implantable medical device
US6071952A (en) *	1998-12-02	2000-06-06	Mylan Pharmaceuticals, Inc.	Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
US6040330A (en) *	1999-01-08	2000-03-21	Bionumerik Pharmaceuticals, Inc.	Pharmaceutical formulations of taxanes
US6828346B2 (en) *	1999-10-25	2004-12-07	Supergen, Inc.	Methods for administration of paclitaxel
US6136846A (en) *	1999-10-25	2000-10-24	Supergen, Inc.	Formulation for paclitaxel
JP2004501143A (ja)	2000-06-22	2004-01-15	ニトロメド　インコーポレーテッド	ニトロソ化およびニトロシル化タキサン、組成物および使用方法
CA2440935A1 (en) *	2001-03-13	2002-09-19	Richard Liggins	Micellar drug delivery vehicles and precursors thereto and uses thereof
DE10115740A1 (de)	2001-03-26	2002-10-02	Ulrich Speck	Zubereitung für die Restenoseprophylaxe
EP1392254B1 (de)	2001-04-20	2007-06-06	The University of British Columbia	Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
US20030126788A1 (en) *	2001-11-07	2003-07-10	Colloid Tech. Inc.	Storage stable translucent flammable article
US6537985B1 (en)	2001-11-30	2003-03-25	Phoenix Scientific, Inc.	Antibiotic formulation and a method of making this formulation
KR20050044621A (ko) *	2001-11-30	2005-05-12	브리스톨-마이어스 스큅 컴퍼니	파클리탁셀 용매화물
ATE424187T1 (de) *	2002-07-15	2009-03-15	Alcon Inc	Bioerodierbare folie zur abgabe eines ophthalmischen arzneimittels
DE10244847A1 (de)	2002-09-20	2004-04-01	Ulrich Prof. Dr. Speck	Medizinische Vorrichtung zur Arzneimittelabgabe
AU2006263433B8 (en)	2005-06-29	2011-06-09	Immunogenesis, Inc.	Phosphoramidate alkylator prodrugs
US9943490B2 (en) *	2007-11-05	2018-04-17	The Trustees Of Princeton University	Composite flash-precipitated nanoparticles
DK2231144T3 (da) *	2007-12-24	2014-10-13	Sun Pharma Advanced Res Co Ltd	Nanodispersion
US8946275B2 (en)	2008-10-21	2015-02-03	Threshold Pharmaceuticals, Inc.	Treatment of cancer using hypoxia activated prodrugs
CA2765541A1 (en)	2009-06-19	2010-12-23	Sun Pharma Advanced Research Company Ltd.	Nanodispersion of a drug and process for its preparation
CA2798180A1 (en)	2010-05-03	2011-11-10	Teikoku Pharma Usa, Inc.	Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US20120172796A1 (en)	2010-12-30	2012-07-05	Chappa Ralph A	Composition for intravascular delivery of therapeutic composition
JO3685B1 (ar)	2012-10-01	2020-08-27	Teikoku Pharma Usa Inc	صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN112972419B (zh) *	2019-12-02	2024-03-08	四川科伦药物研究院有限公司	一种白蛋白纳米药物组合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE74244B1 (en) *	1985-10-01	1997-07-16	Bimeda Res Dev Ltd	A process for preparing an antibiotic composition
US5034397A (en) *	1985-12-12	1991-07-23	Bristol-Myers Squibb Co.	Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
US4772589A (en) *	1986-10-29	1988-09-20	Bristol-Myers	Etoposide solution in NMP
WO1990014094A1 (en) *	1989-05-26	1990-11-29	Abbott Laboratories	Injectable clarithromycin composition
US5082863A (en) *	1990-08-29	1992-01-21	Schering Corporation	Pharmaceutical composition of florfenicol
CA2086874E (en) *	1992-08-03	2000-01-04	Renzo Mauro Canetta	Methods for administration of taxol
EP0626171A1 (de) *	1993-05-26	1994-11-30	Winfried Dörnhöfer	Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
TW406020B (en) *	1993-09-29	2000-09-21	Bristol Myers Squibb Co	Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
ATE175875T1 (de) *	1994-09-01	1999-02-15	Upjohn Co	Tirilazad parentale formulierung mit einem co- lösungsmittel
AU4652596A (en) *	1995-01-09	1996-07-31	Atrix Laboratories, Inc.	Liquid polymer delivery system
US5681846A (en) *	1995-03-17	1997-10-28	Board Of Regents, The University Of Texas System	Extended stability formulations for paclitaxel
US5726181A (en) *	1995-06-05	1998-03-10	Bionumerik Pharmaceuticals, Inc.	Formulations and compositions of poorly water soluble camptothecin derivatives
PL186795B1 (pl) *	1995-12-21	2004-02-27	Pfizer	Preparat farmaceutyczny zawierający danofloksacynę
US5773422A (en) *	1996-01-29	1998-06-30	Komer; Gene	Avermectin formulation
US5877205A (en) *	1996-06-28	1999-03-02	Board Of Regents, The University Of Texas System	Parenteral paclitaxel in a stable non-toxic formulation
CA2211949A1 (en) *	1997-07-21	1999-01-29	David Farley Johnson	Nonaqueous compositions for parenteral administration
US5922754A (en) *	1998-10-02	1999-07-13	Abbott Laboratories	Pharmaceutical compositions containing paclitaxel

1998
- 1998-10-30 US US09/183,199 patent/US6017948A/en not_active Expired - Fee Related
1999
- 1999-09-22 CA CA002345697A patent/CA2345697A1/en not_active Abandoned
- 1999-09-22 MX MXPA01004268A patent/MXPA01004268A/es not_active IP Right Cessation
- 1999-09-22 WO PCT/US1999/021990 patent/WO2000025775A1/en not_active Ceased
- 1999-09-22 CN CNB998126624A patent/CN1178655C/zh not_active Expired - Fee Related
- 1999-09-22 IL IL14272099A patent/IL142720A/xx not_active IP Right Cessation
- 1999-09-22 EP EP99951559A patent/EP1124549B1/de not_active Expired - Lifetime
- 1999-09-22 AU AU63977/99A patent/AU775158B2/en not_active Ceased
- 1999-09-22 DE DE69912983T patent/DE69912983D1/de not_active Expired - Lifetime
- 1999-09-22 AT AT99951559T patent/ATE254455T1/de not_active IP Right Cessation
- 1999-09-22 JP JP2000579216A patent/JP2002528494A/ja active Pending

Also Published As

Publication number	Publication date
MXPA01004268A (es)	2002-06-04
DE69912983D1 (de)	2003-12-24
EP1124549A1 (de)	2001-08-22
JP2002528494A (ja)	2002-09-03
ATE254455T1 (de)	2003-12-15
CN1368880A (zh)	2002-09-11
EP1124549B1 (de)	2003-11-19
IL142720A0 (en)	2002-03-10
CN1178655C (zh)	2004-12-08
WO2000025775A1 (en)	2000-05-11
AU775158B2 (en)	2004-07-22
AU6397799A (en)	2000-05-22
CA2345697A1 (en)	2000-05-11
US6017948A (en)	2000-01-25

Legal Events

Date	Code	Title
2005-09-25	FF	Patent granted
2005-09-25	KB	Patent renewed
2010-11-30	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL142720A (en)	2005-03-20	Water-miscible pharmaceutical compositions of paclitaxel
WO2001087824A3 (en)	2002-04-11	7-substituted fused ring tetracycline compounds
WO2003035617A3 (en)	2003-11-13	Derivatives of uk-2a
WO2001034835A3 (en)	2002-01-10	Method for the production of biopolymers with modified properties
AU2002225369A1 (en)	2002-07-08	Photobase generators, curable compositions prepared by using the same and process of curing
IL155263A0 (en)	2003-11-23	Pharmaceutical solutions of modafinil compounds
AU2003285424A1 (en)	2004-05-13	Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
AU1915399A (en)	2000-02-01	Cs-1 peptidomimetics, compositions and methods of using the same
HK1042036A1 (zh)	2002-08-02	钙溶解化合物
AU7027100A (en)	2001-04-17	Novel compounds
AU6339000A (en)	2001-02-19	Serotonergic benzothiophenes
AU4714297A (en)	1998-05-15	Metalloproteinase inhibitors
AU2001262606A1 (en)	2001-12-11	Semi-solid primer compositions
IL139604A0 (en)	2002-02-10	Novel peptides
AU3896899A (en)	1999-11-29	Compositions for the treatment of tumors, and uses thereof
HK1051356A1 (zh)	2003-08-01	钙溶性化合物
AU3883800A (en)	2000-10-23	Hob-bp2h compositions, methods and uses thereof
AU2001270310A1 (en)	2002-01-21	Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same
AU6053698A (en)	1998-08-18	Plasminogen activator as an anti-inflammatory agent
AU7124400A (en)	2001-04-10	Radiation-curable, cyanoacrylate-containing compositions
AU2002230579A1 (en)	2002-05-06	Calcilytic compounds
AU5176299A (en)	2000-02-28	Compound, composition and use
AU4847799A (en)	2000-02-21	High electron mobility transistor
WO1999061598A3 (en)	2000-04-13	Lentiviral vector compositions and methods of use
AU5054099A (en)	2000-02-14	Non-aqueous anthelmintic composition